Body composition indices as predictors of humoral response to mRNA vaccination against COVID-19 in patients on maintenance hemodialysis.
Journal
Clinical nephrology
ISSN: 0301-0430
Titre abrégé: Clin Nephrol
Pays: Germany
ID NLM: 0364441
Informations de publication
Date de publication:
24 Nov 2023
24 Nov 2023
Historique:
accepted:
24
11
2023
medline:
24
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
aheadofprint
Résumé
Patients on maintenance hemodialysis show lower serological response to mRNA vaccines. Main causes that contribute to this phenomenon are uremic milieu and older age. However, there are no data on the impact of body composition parameters to humoral response. In this retrospective study, we used data from adult patients on maintenance hemodialysis who received vaccination with 2 doses of BNT162b2. Quantitative determination of antibodies to SARS-CoV-2 spike (S) protein receptor binding domain was performed using the Elecsys immunoassay. Antibody levels higher than 0.8 and 264 U/mL were considered positive and protective, respectively. Body composition parameters were assessed using multifrequency bioelectrical impedance spectroscopy. Overall, 49 patients were included in the study. Three weeks after the 1 Parameters of body composition correlate and affect antibody response in patients on hemodialysis. The main observation is that immunogenicity of mRNA vaccines is influenced by phase angle and prediction marker.
Identifiants
pubmed: 37997942
pii: 190753
doi: 10.5414/CN111158
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM